AJANTA PHARMA - stock earnings
AJANTPHARM.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 2.0 billion INR | 10.5 billion INR |
| 2023Q4 | 2.1 billion INR | 11.1 billion INR |
| 2023Q3 | 2.0 billion INR | 10.3 billion INR |
| 2023Q2 | 2.1 billion INR | 10.2 billion INR |
| 2023Q1 | 1.2 billion INR | 8.8 billion INR |
| 2022Q4 | 1.3 billion INR | 9.7 billion INR |
| 2022Q3 | 1.6 billion INR | 9.4 billion INR |
| 2022Q2 | 1.7 billion INR | 9.5 billion INR |
| 2022Q1 | 1.5 billion INR | 8.1 billion INR |
| 2021Q4 | 1.9 billion INR | 8.4 billion INR |
| 2021Q3 | 2.0 billion INR | 8.8 billion INR |
| 2021Q2 | 1.7 billion INR | 7.5 billion INR |
| 2021Q1 | 1.6 billion INR | 7.1 billion INR |
| 2020Q4 | 1.8 billion INR | 7.5 billion INR |
| 2020Q3 | 1.7 billion INR | 7.2 billion INR |
| 2020Q2 | 1.5 billion INR | 6.7 billion INR |
| 2020Q1 | 1.3 billion INR | 6.6 billion INR |
| 2019Q4 | 1.1 billion INR | 6.5 billion INR |
| 2019Q3 | 1.2 billion INR | 6.4 billion INR |
| 2019Q2 | 1.1 billion INR | 6.1 billion INR |
| 2019Q1 | 888.9 million INR | 4.8 billion INR |
| 2018Q4 | 669.0 million INR | 4.9 billion INR |
| 2018Q3 | 1.3 billion INR | 5.4 billion INR |
| 2018Q2 | 1.1 billion INR | 5.1 billion INR |
| 2018Q1 | 944.9 million INR | 5.3 billion INR |
| 2017Q4 | 1.5 billion INR | 5.9 billion INR |
| 2017Q3 | 1.3 billion INR | 5.4 billion INR |
| 2017Q2 | 947.9 million INR | 4.7 billion INR |
| 2017Q1 | 1.1 billion INR | 4.8 billion INR |
| 2016Q4 | 1.4 billion INR | 5.3 billion INR |
| 2016Q3 | 1.3 billion INR | 5.2 billion INR |
| 2016Q2 | 1.2 billion INR | 4.7 billion INR |
| 2016Q1 | 1.1 billion INR | 4.3 billion INR |
| 2015Q4 | 1.1 billion INR | 4.7 billion INR |
| 2015Q3 | 999.6 million INR | 4.4 billion INR |
| 2015Q2 | 838.4 million INR | 3.9 billion INR |
| 2015Q1 | 741.4 million INR | 3.5 billion INR |
| 2014Q4 | 930.6 million INR | 4.1 billion INR |
| 2014Q3 | 830.0 million INR | 3.7 billion INR |
| 2014Q2 | 596.6 million INR | 3.2 billion INR |
AJANTPHARM.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 8.2 billion INR | 42.1 billion INR |
| 2023 | 5.9 billion INR | 37.4 billion INR |
| 2022 | 7.1 billion INR | 32.8 billion INR |
| 2021 | 6.5 billion INR | 28.5 billion INR |
| 2020 | 4.7 billion INR | 25.6 billion INR |
| 2019 | 3.9 billion INR | 20.2 billion INR |
| 2018 | 4.7 billion INR | 20.6 billion INR |
| 2017 | 5.1 billion INR | 19.2 billion INR |
| 2016 | 4.0 billion INR | 17.1 billion INR |
| 2015 | 3.1 billion INR | 14.6 billion INR |
| 2014 | 2.3 billion INR | 11.8 billion INR |
| 2013 | 1.1 billion INR | 9.2 billion INR |
| 2012 | 772.7 million INR | 6.8 billion INR |
| 2011 | 507.1 million INR | 5.0 billion INR |
| 2010 | 340.0 million INR | 4.1 billion INR |
| 2009 | 254.3 million INR | 3.5 billion INR |
| 2008 | 218.8 million INR | 3.1 billion INR |
| 2007 | 146.6 million INR | 2.6 billion INR |
| 2006 | 123.5 million INR | 2.3 billion INR |
| 2005 | 98.5 million INR | 2.0 billion INR |
AJANTPHARM.NS
Price: ₹2,381.05
Dividend Yield: 0.02%
Forward Dividend Yield: 2.18%
Payout Ratio: 89.39%
Dividend Per Share: 52.00 INR
Earnings Per Share: 64.67 INR
P/E Ratio: 37.26
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 299.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 19
DGR3: -5.47%
DGR5: 11.32%
DGR10: 30.00%